Oragenics
OGEN
11 hedge funds and large institutions have $8.16M invested in Oragenics in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
13% more capital invested
Capital invested by funds: $7.21M → $8.16M (+$956K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
8% less funds holding
Funds holding: 12 → 11 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$72.7K |
| 2 |
VF
Virtu Financial
New York
|
+$6.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 2 |
Goldman Sachs
New York
|
-$14K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TS
1
Third Security
Radford,
Virginia
| $6.5M | – | – | – |
|
|
MP
2
MSD Partners
New York
| $724K | – | – | – |
|
3
Fidelity Investments
Boston,
Massachusetts
| $700K | – | – | – |
|
|
4
Bank of New York Mellon
New York
| $84K | +$72.7K | +11 | New |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $45K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $37K | – | – | – |
|
|
BCM
7
Bridgeway Capital Management
Houston,
Texas
| $19K | – | – | – |
|
|
IA
8
IFP Advisors
Tampa,
Florida
| $13K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $13K | – | – | – |
|
|
GC
10
Guggenheim Capital
Chicago,
Illinois
| $8K | – | – | – |
|
|
HWM
11
Holloway Wealth Management
Gainesville,
Florida
| $6K | – | – | – |
|
|
VF
12
Virtu Financial
New York
| $6K | +$6.61K | +1 | New |
|
13
BlackRock
New York
| $3K | – | – | – |
|
14
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
15
Citadel Advisors
Miami,
Florida
| – | -$18K | -3 | Closed |
|
|
16
Goldman Sachs
New York
| – | -$14K | -2 | Closed |
|
|
17
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2K | – | – |
|
OGEN Hedge Fund Activity: Q3 2017 in Review
11 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2017, worth a combined $8.16M — up 13% from $7.21M a quarter earlier.
Fund positioning in OGEN was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $72.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18K sold.
- 11 institutional investors held Oragenics (OGEN) as of Q3 2017, down from 12 in Q2 2017.
- Funds reported $8.16M of Oragenics stock for Q3 2017, up 13% quarter-over-quarter.
- 2 funds opened new Oragenics positions in Q3 2017 and 2 closed out, a net change of 0 holders.
- The largest Oragenics buyer in Q3 2017 was Bank of New York Mellon, an estimated $72.7K added.
- The largest Oragenics seller in Q3 2017 was Citadel Advisors, an estimated $18K sold.
Based on aggregated 13F filings for Q3 2017.